galactosamine has been researched along with Encephalopathy, Hepatic in 61 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 31 (50.82) | 18.7374 |
1990's | 25 (40.98) | 18.2507 |
2000's | 3 (4.92) | 29.6817 |
2010's | 2 (3.28) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baraldi, M; Borella, P; Caselgrandi, E; Zeneroli, ML | 1 |
Cabrera-Pastor, A; Carda, C; Carratalá, A; Cauli, O; Duszczyk, M; Felipo, V; Gimenez-Garzó, C; González-Usano, A; Hernández-Rabaza, V; Lazarewicz, JW; López-Larrubia, P; Malek, M; Miguel, A; Montoliu, C; Ruiz-Sauri, A; Torregrosa, I; Urios, A | 1 |
Agusti, A; Boix, J; Cauli, O; Felipo, V; Piedrafita, B; Rodrigo, R | 1 |
Butterworth, RF | 1 |
Baine, AM; Chen, F; Gardner, LB; Hori, T; Nguyen, JH; Uemoto, S | 1 |
Basile, AS; Mullen, K | 1 |
Baraldi, M; Zeneroli, ZL | 1 |
Fowler, JM; Jones, EA; Munson, PJ; Schafer, DF; Thakur, AK; Waggoner, JG | 1 |
Chang, TM; Shi, ZQ | 2 |
Hamberger, A; Nyström, B | 1 |
Chang, TM; Shu, CD | 1 |
Chamuleau, RA; Kropveld, D; Oosting, J; Popken, RJ | 1 |
Brody, LE; Jacobs, R; Jones, EA; Pappas, SC; Schafer, DF | 1 |
Ferenci, P; Jones, EA; Pappas, SC; Schafer, DF | 1 |
Blasberg, RG; Fenstermacher, JD; Horowitz, ME; Jones, EA; Molnar, P; Patlak, CS; Schafer, DF; Waggoner, J | 1 |
Baraldi, M; Iuliano, E; Racagni, G; Zeneroli, ML | 1 |
Chang, TM; Tabata, Y | 1 |
Chang, TM; Lister, C | 1 |
Chang, TM; Lister, C; Mohsini, K | 1 |
Dixit, V; Gitnick, G | 1 |
Amiot, B; Bloomer, JR; Cerra, FB; Hu, MY; Hu, WS; McGuire, B; Rao, S; Rollins, MD; Sielaff, TD | 1 |
Basile, AS; Heyes, MP; Li, Y; Saito, K | 1 |
Jauregui, HO; Muller, TE; Mullon, CJ; Naik, S; Press, P; Santangini, H; Solomon, BA; Trenkler, D | 1 |
Amiot, B; Bloomer, JR; Cerra, FB; Hu, MY; Hu, WS; Rollins, MD; Sielaff, TD | 1 |
Fukui, H; Kikuchi, E; Matsumoto, M; Matsumura, M; Tsujii, T; Tsujita, S; Uemura, M | 1 |
Heyes, MP; Markey, SP; Nagamura, Y; Noma, A; Quearry, BJ; Saito, K; Seishima, M | 1 |
Aranda, ED; Martinez, A; Quero, Z; Rivas-Vetencourt, PA; Sorio, L; Vegas, AM; Zerpa, MJ | 1 |
Lang, Z; Si, C; Yu, Y | 1 |
Alison, M; Anilkumar, T; Aslam, M; Poulsom, R; Ryan, CJ | 1 |
Mikami, M; Morimoto, Y; Morishita, H; Tsuji, T; Ukida, M | 1 |
Cerra, FB; Gruetter, R; Nyberg, SL | 1 |
Fukuda, Y; Hayakawa, T; Izuta, S; Kato, O; Yoshida, S | 1 |
Dumoulin, FL; Leifeld, L; Manns, MP; Sauerbruch, T; Spengler, U; Trautwein, C | 1 |
Anilkumar, T; Aslam, M; Ben-Hamida, AJ; Courtney, JM; Gaylor, JD; Khorsandi, SE; Pusey, CD; Ryan, CJ | 1 |
Higashi, T; Nagashima, H; Watanabe, A | 1 |
Chang, TM; Chirito, E; Lister, C; Reiter, B | 1 |
Berk, PD; Blitzer, BL; Butler, J; Goodman, DG; Gralnick, HR; Jones, EA; Kopin, IJ; Teychenne, PF; Towne, D; Waggoner, JG; Walters, I; Weise, V | 1 |
Kobayashi, I; Nagamine, T; Negishi, M; Saito, S; Sato, N; Shimizu, H; Shimomura, Y; Takahashi, M; Uehara, Y; Yamada, S | 1 |
Chen, RD; Hu, HL | 1 |
He, X; Luan, Y | 1 |
Miki, H; Nishioka, M; Takeuchi, H; Touge, T; Yamada, A | 1 |
Basile, AS; Gammal, SH; Jones, EA; Ostrowski, NL; Skolnick, P | 2 |
Hickman, R; Terblanche, J | 1 |
Li, ZM; Niu, Z; Wang, F | 1 |
Aslam, M; Courtney, JM; Ryan, CJ | 1 |
Bassett, ML; Fenstermacher, JD; Jones, EA; Mullen, KD; Scholz, B | 1 |
Jones, EA; Kaminsky-Russ, K; Martin, JV; Mendelson, WB; Mullen, KD | 1 |
Dozeman, R; Zieve, L | 1 |
Basile, AS; Gammal, SH; Jones, EA; Mullen, KD; Skolnick, P | 1 |
Ferenci, P; Hanbauer, I; Jones, EA | 1 |
Ede, RJ; Gove, CD; Hughes, RD; Marshall, W; Williams, R | 1 |
Knudsen, GM; Paulson, OB; Poulsen, HE | 1 |
Chang, TM; Zhou, MX | 1 |
Chang, TM; Dixit, V | 1 |
Chamuleau, RA; de Haan, JG; Deutz, NE; van Gool, J | 1 |
Fujita, S | 1 |
Brachtel, D; Richter, E | 1 |
Bauman, WA; Ferenci, P; Jones, EA; Meryn, S; Pappas, SC | 1 |
Karagiulian, SR; Svanadze, NL | 1 |
3 review(s) available for galactosamine and Encephalopathy, Hepatic
Article | Year |
---|---|
Pathophysiology of hepatic encephalopathy: studies in autopsied brain tissue from hepatic coma patients.
Topics: Amino Acids; Animals; Astrocytes; Biogenic Amines; Brain; Brain Chemistry; Catecholamines; Flumazenil; Galactosamine; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Rabbits; Receptors, GABA-A; Receptors, Muscarinic | 1990 |
Animal models of fulminant hepatic failure.
Topics: Acetaminophen; Animals; Carbon Tetrachloride Poisoning; Disease Models, Animal; Galactosamine; Hepatectomy; Hepatic Artery; Hepatic Encephalopathy; Liver Diseases; Portacaval Shunt, Surgical | 1991 |
[Promotion of regeneration in extensive lesions of the liver (review of the literature)].
Topics: Adult; Animals; Dogs; Galactosamine; Growth Substances; Hepatectomy; Hepatic Encephalopathy; Humans; Liver; Liver Diseases; Liver Extracts; Liver Neoplasms; Liver Regeneration; Liver Transplantation; Male; Rats; Stimulation, Chemical | 1985 |
58 other study(ies) available for galactosamine and Encephalopathy, Hepatic
Article | Year |
---|---|
Decrease of brain zinc in experimental hepatic encephalopathy.
Topics: Animals; Brain; Calcium; Copper; Disease Models, Animal; Galactosamine; Hepatic Encephalopathy; Male; Rats; Rats, Sprague-Dawley; Receptors, GABA; Zinc | 1983 |
Blocking NMDA receptors delays death in rats with acute liver failure by dual protective mechanisms in kidney and brain.
Topics: Animals; Blood-Brain Barrier; Body Temperature; Brain; Brain Edema; Cerebrovascular Circulation; Disease Progression; Dizocilpine Maleate; Drug Evaluation, Preclinical; Excitatory Amino Acid Antagonists; Galactosamine; Glomerular Filtration Rate; Hepatic Encephalopathy; Hyperammonemia; Intracranial Hypertension; Inulin; Kidney; Lactates; Liver Failure; Liver Regeneration; Male; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Time Factors | 2014 |
Acute liver failure-induced death of rats is delayed or prevented by blocking NMDA receptors in brain.
Topics: Ammonia; Animals; Brain; Disease Models, Animal; Disease Progression; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Galactosamine; Hepatic Encephalopathy; Hyperammonemia; Infusion Pumps, Implantable; Liver Failure, Acute; Male; Memantine; Microdialysis; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Severity of Illness Index; Time Factors | 2008 |
Fulminant liver failure models with subsequent encephalopathy in the mouse.
Topics: Animals; Azo Compounds; Disease Models, Animal; Galactosamine; Hepatic Encephalopathy; Liver Failure, Acute; Male; Mice; Mice, Inbred C57BL; Prognosis; Survival Rate; Treatment Outcome; Tumor Necrosis Factor-alpha | 2011 |
Preclinical models of hepatic encephalopathy.
Topics: Animals; Disease Models, Animal; Galactosamine; Hepatic Artery; Hepatic Encephalopathy; Hypertension, Portal; Ligation; Liver Failure; Male; Portacaval Shunt, Surgical; Postoperative Complications; Rats; Rats, Sprague-Dawley; Species Specificity; Suture Techniques; Thioacetamide | 2001 |
Experimental hepatic encephalopathy: changes in the binding of gamma-aminobutyric acid.
Topics: Bicuculline; Binding, Competitive; Brain; Disease Models, Animal; Galactosamine; gamma-Aminobutyric Acid; Hepatic Encephalopathy; Humans; Kinetics; Receptors, Cell Surface; Receptors, GABA-A; Synaptic Membranes; Time Factors | 1982 |
Gamma-aminobutyric acid and benzodiazepine receptors in an animal model of fulminant hepatic failure.
Topics: Animals; Coma; Disease Models, Animal; Female; Flunitrazepam; Galactosamine; Hepatic Encephalopathy; Male; Membrane Proteins; Rabbits; Receptors, Cell Surface; Receptors, GABA-A; Synaptic Membranes; Uremia | 1983 |
Amino acid disturbances in experimental hepatic coma rats.
Topics: Amino Acids; Amino Acids, Branched-Chain; Animals; Brain; Chromatography, High Pressure Liquid; Disease Models, Animal; Galactosamine; Hepatic Encephalopathy; Male; Rats; Rats, Inbred Strains | 1984 |
Effect of charcoal hemoperfusion on amino acid disturbance in experimental hepatic coma.
Topics: Adsorption; Amino Acids; Amino Acids, Branched-Chain; Animals; Charcoal; Chromatography, High Pressure Liquid; Disease Models, Animal; Galactosamine; Hemoperfusion; Hepatic Encephalopathy; Male; Rats; Rats, Inbred Strains; Time Factors | 1984 |
Extra- and intracellular amino acids in the hippocampus during development of hepatic encephalopathy.
Topics: Amino Acids; Animals; Galactosamine; Hepatic Encephalopathy; Hippocampus; Rabbits | 1984 |
Middle molecules in the serum, brain, liver and urine of galactosamine-induced fulminant hepatic failure rats.
Topics: Animals; Brain Chemistry; Chromatography, Gel; Galactosamine; Hepatic Encephalopathy; Liver; Male; Rats; Rats, Inbred Strains; Toxins, Biological | 1983 |
Quantitative analysis of EEG power spectra in experimental hepatic encephalopathy.
Topics: Animals; Diazepam; Electroencephalography; Ether; Galactosamine; Hepatic Encephalopathy; Male; Pentobarbital; Rats; Rats, Inbred Strains | 1983 |
Visual evoked potentials in a rabbit model of hepatic encephalopathy. I. Sequential changes and comparisons with drug-induced comas.
Topics: Animals; Diazepam; Disease Models, Animal; Electrodes; Electroencephalography; Evoked Potentials, Visual; Galactosamine; Hepatic Encephalopathy; Muscimol; Pentobarbital; Rabbits | 1984 |
Visual evoked potentials in a rabbit model of hepatic encephalopathy. II. Comparison of hyperammonemic encephalopathy, postictal coma, and coma induced by synergistic neurotoxins.
Topics: Ammonia; Animals; Caprylates; Disease Models, Animal; Disulfides; Evoked Potentials, Visual; Galactosamine; Hepatic Encephalopathy; Rabbits; Seizures | 1984 |
Increased blood-brain transfer in a rabbit model of acute liver failure.
Topics: Aminoisobutyric Acids; Animals; Autoradiography; Biological Transport, Active; Blood-Brain Barrier; Capillary Permeability; Carbon Radioisotopes; Chemical and Drug Induced Liver Injury; Galactosamine; Hepatic Encephalopathy; Liver Diseases; Rabbits | 1983 |
Metabolism and brain uptake of gamma-aminobutyric acid in galactosamine-induced hepatic encephalopathy in rats.
Topics: Animals; Brain; Galactosamine; gamma-Aminobutyric Acid; Glutamate Decarboxylase; Hepatic Encephalopathy; Kinetics; Male; Rats; Time Factors | 1982 |
Comparisons of six artificial liver support regimes in fulminant hepatic coma rats.
Topics: Albumins; Animals; Charcoal; Exchange Transfusion, Whole Blood; Galactosamine; Hemoperfusion; Hepatic Encephalopathy; Male; Rats; Time Factors | 1980 |
Middle molecules in hepatic coma and uremia.
Topics: Animals; Blood Chemical Analysis; Disease Models, Animal; Galactosamine; Hemoperfusion; Hepatic Encephalopathy; Humans; Kidney Failure, Chronic; Rats; Reference Values; Toxins, Biological; Uremia | 1981 |
The effects of homologous cross-circulation and in situ liver perfusion on fulminant hepatic failure rats.
Topics: Animals; Cross Circulation; Galactosamine; Hemoperfusion; Hepatic Encephalopathy; Liver; Male; Parabiosis; Perfusion; Prognosis; Rats | 1980 |
Transplantation of microencapsulated hepatocytes for liver function replacement.
Topics: Animals; Artificial Organs; Biodegradation, Environmental; Cell Membrane Permeability; Cell Survival; Cell Transplantation; Cryopreservation; Disease Models, Animal; Drug Compounding; Galactosamine; Hepatic Encephalopathy; Immunosuppression Therapy; Liver; Liver Diseases; Liver Function Tests; Male; Rats; Rats, Wistar | 1995 |
Gel-entrapment bioartificial liver therapy in galactosamine hepatitis.
Topics: Animals; Artificial Organs; Dogs; Galactosamine; Hemoperfusion; Hepatic Encephalopathy; Liver; Male; Swine | 1995 |
The relationship between plasma and brain quinolinic acid levels and the severity of hepatic encephalopathy in animal models of fulminant hepatic failure.
Topics: Animals; Brain; Galactosamine; Hepatic Encephalopathy; Male; Osmolar Concentration; Quinolinic Acid; Rabbits; Rats; Rats, Sprague-Dawley; Thioacetamide | 1995 |
In vivo evaluation of a hollow fiber liver assist device.
Topics: Animals; Artificial Organs; Diazepam; Evaluation Studies as Topic; Extracorporeal Circulation; Galactosamine; Hepatic Encephalopathy; Lidocaine; Liver; Male; Rabbits | 1995 |
An anesthetized model of lethal canine galactosamine fulminant hepatic failure.
Topics: Anesthesia; Animals; Disease Models, Animal; Dogs; Galactosamine; Halothane; Hepatic Encephalopathy; Liver; Male | 1995 |
Effect of prostaglandin E1 on experimental acute hepatic failure in rabbits: prostaglandin E1 prevents the development of multiple-organ failure.
Topics: Alprostadil; Animals; Galactosamine; Hepatic Encephalopathy; Male; Multiple Organ Failure; Rabbits; Regional Blood Flow | 1994 |
Kynurenine pathway metabolism in the galactosamine model of hepatic injury.
Topics: Animals; Brain; Female; Galactosamine; Gerbillinae; Hepatic Encephalopathy; Kynurenine; Lipopolysaccharides; Liver; Lung; Quinolinic Acid; Salmonella; Tryptophan Oxygenase | 1996 |
Combined xenotransplantation of encapsulated hepatocytes and pancreatic islets.
Topics: Animals; Capsules; Cell Separation; Cell Transplantation; Diabetes Mellitus, Type 1; Galactosamine; Hepatectomy; Hepatic Encephalopathy; Islets of Langerhans; Islets of Langerhans Transplantation; Liver; Liver Function Tests; Liver, Artificial; Pancreas, Artificial; Pancreatectomy; Rats; Rats, Sprague-Dawley; Swine; Transplantation, Heterologous | 1997 |
[The effect of tumor necrosis factor alpha on hepatic necrosis in viral hepatitis].
Topics: Adult; Aged; Animals; Female; Galactosamine; Hepatic Encephalopathy; Hepatitis, Animal; Hepatitis, Viral, Human; Humans; Immunohistochemistry; Liver; Male; Middle Aged; Necrosis; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha | 1996 |
The anti-proliferative effect of plasma from rats with acute fulminant hepatic failure.
Topics: Acute Disease; Animals; Blood Donors; Bromodeoxyuridine; Cell Division; Female; Galactosamine; Growth Inhibitors; Hepatectomy; Hepatic Encephalopathy; Immunohistochemistry; Immunophenotyping; Liver; Liver Regeneration; Mitotic Index; Organ Size; Plasma; Plasma Exchange; Rats; Rats, Sprague-Dawley | 1997 |
A 15N GC/MS study of in vivo glutamine synthesis in liver failure rats.
Topics: Animals; Galactosamine; Gas Chromatography-Mass Spectrometry; Glutamine; Hepatic Encephalopathy; Injections, Intraperitoneal; Injections, Intravenous; Leucine; Male; Nitrogen Isotopes; Rats; Rats, Sprague-Dawley | 1997 |
Brain lactate by magnetic resonance spectroscopy during fulminant hepatic failure in the dog.
Topics: Animals; Biomarkers; Brain; Dogs; Dose-Response Relationship, Drug; Feasibility Studies; Galactosamine; Glutamic Acid; Glutamine; Hepatic Encephalopathy; Intracranial Hypertension; Lactic Acid; Magnetic Resonance Spectroscopy; Male; Time Factors | 1998 |
Serum DNA polymerase beta as an indicator for fatal liver injury of rat induced by D-galactosamine hydrochloride and lipopolysaccharide.
Topics: Alanine Transaminase; Animals; Biomarkers; DNA Polymerase beta; Dose-Response Relationship, Drug; Galactosamine; Hepatic Encephalopathy; Lipopolysaccharides; Liver; Male; Predictive Value of Tests; Prognosis; Rats; Rats, Wistar; Time Factors | 1998 |
Enhanced expression of CD80 (B7-1), CD86 (B7-2), and CD40 and their ligands CD28 and CD154 in fulminant hepatic failure.
Topics: Animals; Antigens, CD; B7-1 Antigen; B7-2 Antigen; CD28 Antigens; CD40 Antigens; CD40 Ligand; Galactosamine; Hepatic Encephalopathy; Humans; Kupffer Cells; Lipopolysaccharides; Male; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; Tumor Necrosis Factor-alpha; Up-Regulation | 1999 |
Multisorbent plasma perfusion in fulminant hepatic failure: effects of duration and frequency of treatment in rats with grade III hepatic coma.
Topics: Animals; Disease Models, Animal; Female; Galactosamine; Hepatic Encephalopathy; Liver Failure, Acute; Liver Regeneration; Liver, Artificial; Perfusion; Plasma; Rats; Rats, Sprague-Dawley; Reference Values; Sensitivity and Specificity; Severity of Illness Index; Survival Rate; Treatment Outcome | 2001 |
An animal model of fulminant hepatic failure in the rat.
Topics: Amino Acids; Animals; Brain; Brain Chemistry; Brain Edema; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Galactosamine; Hepatic Encephalopathy; Liver; Liver Diseases; Male; Rats | 1979 |
Artificial liver: the effect of ACAC microencapsulated charcoal hemoperfusion on fulminant hepatic failure.
Topics: Albumins; Animals; Artificial Organs; Charcoal; Collodion; Disease Models, Animal; Galactosamine; Hemoperfusion; Hepatic Encephalopathy; Humans; Liver; Liver Diseases; Rats | 1977 |
A model of fulminant hepatic failure in the rabbit.
Topics: Alkaline Phosphatase; Amino Acids; Ammonia; Animals; Aspartate Aminotransferases; Blood Coagulation Tests; Blood Glucose; Creatinine; Disease Models, Animal; Electroencephalography; Galactosamine; Hepatic Encephalopathy; L-Lactate Dehydrogenase; Liver; Rabbits | 1978 |
Feeding behavior and ambulatory activity in rats with D-galactosamine-induced hepatic failure.
Topics: Amino Acids, Branched-Chain; Animals; Circadian Rhythm; Consummatory Behavior; Corpus Striatum; Feeding Behavior; Galactosamine; Hepatic Encephalopathy; Male; Motor Activity; Neurotransmitter Agents; Phenylalanine; Rats; Rats, Inbred Strains; Tryptophan | 1992 |
Changes in free radicals, trace elements, and neurophysiological function in rats with liver damage induced by D-galactosamine.
Topics: Alanine Transaminase; Animals; Brain; Evoked Potentials, Visual; Free Radicals; Galactosamine; Hepatic Encephalopathy; Liver; Male; Prealbumin; Rats; Rats, Wistar; Trace Elements | 1992 |
[Study on variation of plasma gamma-aminobutyric acid concentration in rat model of hepatic encephalopathy due to fulminant hepatic failure].
Topics: Animals; Galactosamine; gamma-Aminobutyric Acid; Hepatic Encephalopathy; Male; Rats; Rats, Inbred Strains | 1992 |
[Decreased dopaminergic activity in hepatic encephalopathy in rats with galactosamine-induced acute liver failure].
Topics: Acute Disease; Animals; Dopamine; Electrophysiology; Galactosamine; Hepatic Encephalopathy; Male; Neurons; Rats; Rats, Inbred Strains; Substantia Nigra | 1992 |
The involvement of the benzodiazepine receptor in hepatic encephalopathy: evidence for the presence of a benzodiazepine receptor ligand.
Topics: Animals; Autoradiography; Brain Chemistry; Disease Models, Animal; GABA-A Receptor Antagonists; Galactosamine; Hepatic Encephalopathy; Ligands; Rabbits; Receptors, GABA-A | 1990 |
Plasma gamma-aminobutyric acid in experimental fulminant hepatic failure of rats and its diagnostic value in hepatic encephalopathy.
Topics: Alanine Transaminase; Animals; Chemical and Drug Induced Liver Injury; Galactosamine; gamma-Aminobutyric Acid; Hepatic Encephalopathy; Liver Diseases; Male; Rats; Rats, Inbred Strains | 1990 |
The GABAA receptor complex in hepatic encephalopathy. Autoradiographic evidence for the presence of elevated levels of a benzodiazepine receptor ligand.
Topics: Animals; Autoradiography; Brain; Flunitrazepam; Galactosamine; Hepatic Encephalopathy; Muscimol; Organ Specificity; Rabbits; Receptors, GABA-A; Reference Values; Sodium Chloride; Tritium; Up-Regulation | 1990 |
Transference of hepatic coma to normal rats from galactosamine treated donors by reverse plasma exchange.
Topics: Animals; Female; Galactosamine; Hepatic Encephalopathy; Plasma Exchange; Rats; Rats, Inbred Strains | 1990 |
Increased brain uptake of gamma-aminobutyric acid in a rabbit model of hepatic encephalopathy.
Topics: Animals; Brain; Butanols; Carbon Radioisotopes; Disease Models, Animal; Galactosamine; gamma-Aminobutyric Acid; Half-Life; Hepatic Encephalopathy; Indium Radioisotopes; Methods; Rabbits; Time Factors; Transferrin; Tritium | 1990 |
Evidence for the presence of a benzodiazepine receptor binding substance in cerebrospinal fluid of a rabbit model of hepatic encephalopathy.
Topics: Aminocaproates; Animals; Binding, Competitive; Flumazenil; GABA-A Receptor Antagonists; Galactosamine; Hepatic Encephalopathy; Hypoxanthine; Hypoxanthines; Male; Rabbits; Radioligand Assay; Receptors, GABA-A; Vigabatrin | 1989 |
Effect of hepatic failure toxins on regenerative enzymes in the liver after injury with galactosamine in the rat.
Topics: Acetaminophen; Ammonium Chloride; Animals; Caprylates; Chemical and Drug Induced Liver Injury; Disulfides; Galactosamine; Hepatic Encephalopathy; Liver Diseases; Liver Regeneration; Male; Ornithine Decarboxylase Inhibitors; Rats; Rats, Inbred Strains; Thymidine Kinase; Time Factors | 1989 |
Differential responsiveness of cerebellar Purkinje neurons to GABA and benzodiazepine receptor ligands in an animal model of hepatic encephalopathy.
Topics: Animals; Benzodiazepines; Flumazenil; Flunitrazepam; GABA Antagonists; Galactosamine; Hepatic Encephalopathy; Ligands; Male; Muscimol; Purkinje Cells; Rabbits; Receptors, GABA-A | 1988 |
Lack of evidence for impaired dopamine receptor function in experimental hepatic coma in the rabbit.
Topics: Adenylyl Cyclases; Animals; Corpus Striatum; Galactosamine; Hepatic Encephalopathy; Kinetics; Rabbits; Receptors, Dopamine; Synaptic Transmission | 1986 |
Reduced brain Na+, K+-ATPase activity in rats with galactosamine-induced hepatic failure: relationship to encephalopathy and cerebral oedema.
Topics: Acute Disease; Animals; Brain; Brain Edema; Chemical and Drug Induced Liver Injury; Galactosamine; Hepatic Encephalopathy; Male; Rats; Rats, Inbred Strains; Sodium-Potassium-Exchanging ATPase | 1987 |
Blood-brain barrier permeability in galactosamine-induced hepatic encephalopathy. No evidence for increased GABA-transport.
Topics: Animals; Blood-Brain Barrier; Galactosamine; gamma-Aminobutyric Acid; Hepatic Encephalopathy; Male; Rats; Rats, Inbred Strains; Sodium; Sucrose | 1988 |
Effects of polylactic acid microcapsules containing prostaglandin E2 on the survival rates of grade II coma galactosamine induced fulminant hepatic failure rats.
Topics: Animals; Capsules; Delayed-Action Preparations; Dinoprostone; Galactosamine; Hepatic Encephalopathy; Lactates; Lactic Acid; Male; Polyesters; Polymers; Prostaglandins E; Rats; Rats, Inbred Strains | 1987 |
Effects of prostaglandin E2 on brain edema and liver histopathology in a galactosamine-induced fulminant hepatic failure rat model.
Topics: Animals; Blood-Brain Barrier; Brain Edema; Dinoprostone; Galactosamine; Hepatic Encephalopathy; Liver; Male; Microscopy, Electron; Prostaglandins E; Rats; Rats, Inbred Strains | 1987 |
Correlation between electroencephalographic and biochemical indices in acute hepatic encephalopathy in rats.
Topics: Acute Disease; Alanine Transaminase; Amino Acids; Ammonia; Animals; Disease Models, Animal; Electroencephalography; Galactosamine; Hepatic Encephalopathy; Humans; Rats; Rats, Inbred Strains | 1987 |
[An electron microscopic histochemical study of the blood-brain barrier in acute hepatic failure induced by D-galactosamine].
Topics: Animals; Blood-Brain Barrier; Cerebral Cortex; Galactosamine; Hepatic Encephalopathy; Male; Rats; Rats, Inbred Strains | 1987 |
[Galactosamine-induced acute liver failure in the guinea pig--spontaneous course and controlled study conditions].
Topics: Acute Disease; Animals; Blood Glucose; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Dose-Response Relationship, Drug; Galactosamine; Guinea Pigs; Hepatic Encephalopathy; Liver; Liver Function Tests; Male; Necrosis | 1986 |
Brain cholecystokinin and vasoactive intestinal polypeptide: immunoreactivity in rabbits with hepatic coma.
Topics: Animals; Brain; Cerebellum; Cerebral Cortex; Cholecystokinin; Galactosamine; Hepatic Encephalopathy; Hypothalamus; Molecular Weight; Rabbits; Vasoactive Intestinal Peptide | 1986 |